Markets

Radius Health prices IPO at $8 as expected

Radius Health, which is developing treatments to restore bone density in osteoporosis patients, raised $52 million by offering 6.5 million shares at $8, the revised IPO price. The company originally filed to offer 5.0 million shares at $14 to $16 per share before postponing in early May. Radius Health will list on the NASDAQ under the symbol RDUS. Jefferies and Cowen & Company acted as joint bookrunners on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

RDUS

Other Topics

IPOs

Latest Markets Videos

    Renaissance Capital

    Renaissance Capital is the global leader in providing pre-IPO institutional research and management of IPO-focused investment products.

    Learn More